Patient Portal

Matthew A. Powell, MD

Professor, Obstetrics and Gynecology
Chief, Division of Gynecologic Oncology

Specialty Areas

Gynecologic Oncology
Cervical Cancer
Ovarian Cancer
Endometrial Cancer

Board Certifications

Gynecologic Oncology
Obstetrics and Gynecology

Hospital Affiliations

Barnes-Jewish Hospital
Missouri Baptist Medical Center
St. Louis Children's Hospital
Progress West Hospital

Areas of Clinical Interest

Gynecologic oncology, endometrial cancer, vulva carcinoma, ovarian cancer, cervical cancer, adnexal masses, tumors, hysterectomy, lymphadenectomy, endometrial adenocarcinomas, cervical intraepithelial neoplasia, gynecologic malignancies, ob/gyn, women's health

  • Location(s)
  • Education
  • Publication & Research
  • Financial Disclosures

Location(s)

Location(s)

Missouri Baptist Medical Center
Building D

3023 N. Ballas Road
Fourth Floor, Suite 450
St. Louis, MO 63131

Floor: Building D, Fourth Floor, Suite 450
Office Phone: 314-996-6075
Fax: 314-996-6074

Center for Advanced Medicine
Gynecologic Treatment Center

4921 Parkview Place
St. Louis, MO 63110

Suite: C
Floor: 13
Office Phone: 314-362-3181
Fax: 866-282-1113

Education

Education

Fellowship: Gynecologic Oncology, Washington University School of Medicine, St. Louis, Missouri 2002
Residency: Obstetrics and Gynecology, Ohio State University Hospital and Clinics, Columbus, Ohio 1999
Medical Degree: Michigan State University College of Human Medicine, East Lansing, Michigan 1995
B.S.: Biochemistry and Biophysics, Washington State University, Pullman, Washington 1990
Research Fellow: University of Washington, Northwest College and University Association for Science, Richland, Washington 1989

Publication & Research

Publication & Research

Optical Resolution Photoacoustic Microscopy of Ovary and Fallopian Tube.
Rao B, Leng X, Zeng Y, Lin Y, Chen R, Zhou Q, Hagemann AR, Kuroki LM, McCourt CK, Mutch DG, Powell MA, Hagemann IS, Zhu Q
Sci Rep. 2019 Oct 4; 9(1)14306. doi: 10.1038/s41598-019-50743-7.

PMID:
    31586106
    [PubMed - in process]
Related citations


Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with <sup>18</sup>F-fluorodeoxyglucose-positron emission tomography in stage IB cervical cancer.
Lin AJ, Wright JD, Dehdashti F, Siegel BA, Markovina S, Schwarz J, Thaker PH, Mutch DG, Powell MA, Grigsby PW
Int J Gynecol Cancer. 2019 Aug 30; pii: ijgc-2019-000528. doi: 10.1136/ijgc-2019-000528.

PMID:
    31473660
    [PubMed - as supplied by publisher]
Related citations


Patients with endometrial cancer continue to lack understanding of their risks for cancer.
Sekhon S, Massad LS, Hagemann AR, Dick R, Leon A, Zamorano AS, Thaker PH, McCourt CK, Mutch DG, Powell MA, Kuroki LM
Gynecol Oncol Rep. 2019 Aug; 29106-110. doi: 10.1016/j.gore.2019.07.013.

PMID:
    31467962
    [PubMed]
Related citations


Risk of cervical and vaginal dysplasia after surgery for vulvar intraepithelial neoplasia or cancer: A 6 year follow-up study.
Buchanan TR, Zamorano AS, Massad LS, Liu J, Thaker PH, Powell MA, Mutch DG, Kuroki LM
Gynecol Oncol. 2019 Oct; 155(1)88-92. doi: 10.1016/j.ygyno.2019.07.017.

PMID:
    31375270
    [PubMed - in process]
Related citations


Histogram analysis of en face scattering coefficient map predicts malignancy in human ovarian tissue.
Zeng Y, Nandy S, Rao B, Li S, Hagemann AR, Kuroki LK, McCourt C, Mutch DG, Powell MA, Hagemann IS, Zhu Q
J Biophotonics. 2019 Jul 14; e201900115. doi: 10.1002/jbio.201900115.

PMID:
    31304678
    [PubMed - as supplied by publisher]
Related citations


Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next?
Mills KA, Lopez H, Sun L, Cripe JC, Litz T, Thaker PH, Powell MA, Mutch DG, Fuh KC
Gynecol Oncol Rep. 2019 Aug; 2920-24. doi: 10.1016/j.gore.2019.05.007.

PMID:
    31193699
    [PubMed]
Related citations


Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer.
Matei D, Filiaci V, Randall ME, Mutch D, Steinhoff MM, DiSilvestro PA, Moxley KM, Kim YM, Powell MA, O'Malley DM, Spirtos NM, Small W Jr, Tewari KS, Richards WE, Nakayama J, Matulonis UA, Huang HQ, Miller DS
N Engl J Med. 2019 Jun 13; 380(24)2317-2326. doi: 10.1056/NEJMoa1813181.

PMID:
    31189035
    [PubMed - indexed for MEDLINE]
Related citations


Do gynecologic oncology patients with severely diminished renal function and urinary tract obstruction benefit from ureteral stenting or percutaneous nephrostomy?
Liang B, Lange SS, Massad LS, Dick R, Mills KA, Hagemann AR, McCourt CK, Thaker PH, Fuh KC, Mutch DG, Powell MA, Kuroki LM
Gynecol Oncol Rep. 2019 May; 28136-140. doi: 10.1016/j.gore.2019.04.007.

PMID:
    31061871
    [PubMed]
Related citations


Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
Walker JL, Brady MF, Wenzel L, Fleming GF, Huang HQ, DiSilvestro PA, Fujiwara K, Alberts DS, Zheng W, Tewari KS, Cohn DE, Powell MA, Van Le L, Davidson SA, Gray HJ, Rose PG, Aghajanian C, Myers T, Alvarez Secord A, Rubin SC, Mannel RS
J Clin Oncol. 2019 Jun 1; 37(16)1380-1390. doi: 10.1200/JCO.18.01568.

PMID:
    31002578
    [PubMed - in process]
Related citations


Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation.
Lin AJ, Ma S, Markovina S, Schwarz J, Mutch DG, Powell MA, Grigsby PW
Gynecol Oncol. 2019 Jun; 153(3)530-534. doi: 10.1016/j.ygyno.2019.03.104.

PMID:
    30905434
    [PubMed - indexed for MEDLINE]
Related citations


Wound Complication Rates After Vulvar Excisions for Premalignant Lesions.
Mullen MM, Merfeld EC, Palisoul ML, Massad LS, Woolfolk C, Powell MA, Mutch DG, Thaker PH, Hagemann AR, Kuroki LM
Obstet Gynecol. 2019 Apr; 133(4)658-665. doi: 10.1097/AOG.0000000000003185.

PMID:
    30870300
    [PubMed - in process]
Related citations


Targeted metabolomic profiling of low and high grade serous epithelial ovarian cancer tissues: a pilot study.
Garg G, Yilmaz A, Kumar P, Turkoglu O, Mutch DG, Powell MA, Rosen B, Bahado-Singh RO, Graham SF
Metabolomics. 2018 Nov 24; 14(12)154. doi: 10.1007/s11306-018-1448-3.

PMID:
    30830441
    [PubMed - indexed for MEDLINE]
Related citations


GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group study.
Brooks RA, Tritchler DS, Darcy KM, Lankes HA, Salani R, Sperduto P, Guntupalli S, DiSilvestro P, Kesterson J, Olawaiye AB, Moxley K, Waggoner S, Santin A, Rader JS, Kizer NT, Thaker PH, Powell MA, Mutch DG, Birrer MJ, Goodfellow PJ
Gynecol Oncol. 2019 May; 153(2)335-342. doi: 10.1016/j.ygyno.2019.02.028.

PMID:
    30827726
    [PubMed - indexed for MEDLINE]
Related citations


Continuous epidural infusion in gynecologic oncology patients undergoing exploratory laparotomy: The new standard for decreased postoperative pain and opioid use.
Huepenbecker SP, Cusworth SE, Kuroki LM, Lu P, Samen CDK, Woolfolk C, Deterding R, Wan L, Helsten DL, Bottros M, Mutch DG, Powell MA, Massad LS, Thaker PH
Gynecol Oncol. 2019 May; 153(2)356-361. doi: 10.1016/j.ygyno.2019.02.017.

PMID:
    30798950
    [PubMed - indexed for MEDLINE]
Related citations


Association between body mass index and surgical menopausal symptoms in patients with early stage endometrial cancer.
Cripe JC, Buchanan TR Jr, Kuroki LM, Wan L, Mills KA, Massad L, Hagemann AR, Fuh KC, Mutch DG, Powell MA, Matsuo K, Thaker PH
Gynecol Oncol. 2019 Apr; 153(1)123-126. doi: 10.1016/j.ygyno.2019.01.009.

PMID:
    30651188
    [PubMed - indexed for MEDLINE]
Related citations


Obesity counseling in obstetrics and gynecology: provider perceptions and barriers.
Huepenbecker SP, Wan L, Leon A, Rosen D, Hoff J, Kuroki LM, Fuh KC, Powell MA, Mutch DG, Colditz GA, Hagemann AR
Gynecol Oncol Rep. 2019 Feb; 2731-34. doi: 10.1016/j.gore.2018.12.001.

PMID:
    30582746
    [PubMed]
Related citations


Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer.
Quinn JM, Greenwade MM, Palisoul ML, Opara G, Massad K, Guo L, Zhao P, Beck-Noia H, Hagemann IS, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Fuh KC
Mol Cancer Ther. 2019 Feb; 18(2)389-398. doi: 10.1158/1535-7163.MCT-18-0537.

PMID:
    30478151
    [PubMed - in process]
Related citations


Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer.
Lin AJ, Kidd E, Dehdashti F, Siegel BA, Mutic S, Thaker PH, Massad LS, Powell MA, Mutch DG, Markovina S, Schwarz J, Grigsby PW
Int J Radiat Oncol Biol Phys. 2019 Apr 1; 103(5)1088-1097. doi: 10.1016/j.ijrobp.2018.11.012.

PMID:
    30445171
    [PubMed - indexed for MEDLINE]
Related citations


Evaluation of Ovarian Cancer: Initial Application of Coregistered Photoacoustic Tomography and US.
Nandy S, Mostafa A, Hagemann IS, Powell MA, Amidi E, Robinson K, Mutch DG, Siegel C, Zhu Q
Radiology. 2018 Dec; 289(3)740-747. doi: 10.1148/radiol.2018180666.

PMID:
    30204078
    [PubMed - indexed for MEDLINE]
Related citations


SQ1274, a novel microtubule inhibitor, inhibits ovarian and uterine cancer cell growth.
Mills KA, Roach ST, Quinn JM, Guo L, Beck HM, Lomonosova E, Ilivicky AR, Starks CM, Lawrence JA, Hagemann AR, McCourt C, Thaker PH, Powell MA, Mutch DG, Fuh KC
Gynecol Oncol. 2018 Nov; 151(2)337-344. doi: 10.1016/j.ygyno.2018.08.008.

PMID:
    30190114
    [PubMed - indexed for MEDLINE]
Related citations

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following financial interests during calendar year 2018:

Company Name: Astrazeneca Pharmaceuticals LP

Royalties:

Equity: No

Consulting/Advisory Board: $10,000 - $19,999

Speaker Fees:

Reporting Date: May 01, 2019


Company Name: Clovis Oncology, Inc.

Royalties:

Equity: No

Consulting/Advisory Board: $20,000 - $39,999

Speaker Fees:

Reporting Date: May 01, 2019


Company Name: Genentech, Inc.

Royalties:

Equity: No

Consulting/Advisory Board: $10,000 - $19,999

Speaker Fees:

Reporting Date: May 01, 2019


Company Name: Merck Sharp & Dohme Corporation

Royalties:

Equity: No

Consulting/Advisory Board: $1 - $9,999

Speaker Fees: $1 - $9,999

Reporting Date: May 01, 2019